Coloplast A/S (OTCMKTS:CLPBY) Upgraded to Hold at Hsbc Global Res

Hsbc Global Res upgraded shares of Coloplast A/S (OTCMKTS:CLPBY) from a moderate sell rating to a hold rating in a research report released on Monday,Zacks.com reports.

Coloplast A/S Trading Down 1.2 %

CLPBY opened at $12.60 on Monday. Coloplast A/S has a 12 month low of $10.69 and a 12 month high of $14.34. The company has a debt-to-equity ratio of 1.00, a quick ratio of 0.56 and a current ratio of 0.85. The company has a fifty day simple moving average of $13.07 and a 200 day simple moving average of $12.86.

Coloplast A/S (OTCMKTS:CLPBY) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $0.08 earnings per share (EPS) for the quarter. The company had revenue of $1.02 billion during the quarter. Coloplast A/S had a return on equity of 31.17% and a net margin of 18.69%. On average, analysts predict that Coloplast A/S will post 0.38 EPS for the current fiscal year.

Coloplast A/S Increases Dividend

The business also recently announced a dividend, which will be paid on Friday, December 20th. Investors of record on Monday, December 9th will be paid a $0.2435 dividend. The ex-dividend date is Monday, December 9th. This is a positive change from Coloplast A/S’s previous dividend of $0.05. Coloplast A/S’s dividend payout ratio is presently 27.27%.

Coloplast A/S Company Profile

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.